Companies / Opus Genetics, Inc. / Activity
Activity — Opus Genetics, Inc.
32 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sell | Common Stock | $7.39M | -1.7M -30.95% | 3,792,171 4.56% of shares | medium |
| Mar 16, 2026 | Magrath George CEO | Sell | Common Stock | $127.3K | -24K -1.38% | 1,750,855 2.10% of shares | medium |
| Apr 23, 2026 | Magrath George CEO | Sell | Common Stock | $49.6K | -10K -0.54% | 1,741,344 2.09% of shares | low |
| Apr 23, 2026 | Gagnon Robert E. Executive | Sell | Common Stock | $40.7K | -8K -1.31% | 592,158 0.71% of shares | low |
| Apr 23, 2026 | Jayagopal Ashwath Executive | Sell | Common Stock | $39.2K | -8K -1.46% | 509,233 0.61% of shares | low |
| Apr 23, 2026 | Yerxa Benjamin R Executive | Sell | Common Stock | $39.1K | -7K -1.04% | 711,535 0.86% of shares | low |
| Apr 23, 2026 | Schachle Joseph K Executive | Sell | Common Stock | $24.5K | -5K -1.56% | 296,084 0.36% of shares | low |
| Mar 16, 2026 | Schachle Joseph K Executive | Sell | Common Stock | $19.5K | -4K -1.22% | 300,781 0.36% of shares | low |
| Mar 16, 2026 | Jayagopal Ashwath Executive | Sell | Common Stock | $19.0K | -4K -0.71% | 516,775 0.62% of shares | low |
| Feb 12, 2026 | Jayagopal Ashwath Executive | Other | Common Stock | $18.0K | -5K -1.01% | 520,494 0.63% of shares | low |
| Mar 16, 2026 | Zaremba Rabourn Amy Executive | Sell | Common Stock | $14.8K | -3K -1.46% | 190,312 0.23% of shares | low |
| Apr 23, 2026 | Zaremba Rabourn Amy Executive | Sell | Common Stock | $8.5K | -2K -0.86% | 188,671 0.23% of shares | low |
| Jan 10, 2026 | Zaremba Rabourn Amy Executive | Other | Common Stock | $7.6K | -4K -3.47% | 110,018 0.13% of shares | low |
| Jan 18, 2026 | Zaremba Rabourn Amy Executive | Other | Common Stock | $7.1K | -3K -3.08% | 106,628 0.13% of shares | low |
| Apr 20, 2026 | Rodgers Richard J Director | Grant | Common Stock | $0 | +24K +7.65% | 343,022 0.41% of shares | low |
| Apr 20, 2026 | Manuso James S J Director | Grant | Common Stock | $0 | +24K +8.32% | 317,318 0.38% of shares | low |
| Apr 20, 2026 | Graves Adrienne L Director | Grant | Common Stock | $0 | +24K +23.62% | 127,514 0.15% of shares | low |
| Apr 20, 2026 | Gallagher Cam Director | Grant | Common Stock | $0 | +24K +1.22% | 2,015,797 2.42% of shares | low |
| Apr 20, 2026 | Benton Susan Director | Grant | Common Stock | $0 | +24K +11.10% | 243,894 0.29% of shares | low |
| Apr 20, 2026 | Bennett Jean Director | Grant | Common Stock | $0 | +24K +10.38% | 259,019 0.31% of shares | low |
| Apr 20, 2026 | Ainsworth Sean Director | Grant | Common Stock | $0 | +24K +8.20% | 321,692 0.39% of shares | low |
| Jan 22, 2026 | Zaremba Rabourn Amy Executive | Grant | Common Stock | $0 | +87K +81.12% | 193,128 0.23% of shares | low |
| Jan 6, 2026 | Gallagher Cam Director | Grant | Common Stock | $0 | +67K +3.48% | 1,991,430 2.39% of shares | low |
| Jan 22, 2026 | Gagnon Robert E. Executive | Grant | Common Stock | $0 | +400K +200.00% | 600,000 0.72% of shares | low |
| Jan 22, 2026 | Yerxa Benjamin R Executive | Grant | Common Stock | $0 | +400K +125.39% | 719,005 0.86% of shares | low |
| Jan 22, 2026 | Schachle Joseph K Executive | Grant | Common Stock | $0 | +250K +458.72% | 304,500 0.37% of shares | low |
| Jan 22, 2026 | Magrath George CEO | Grant | Common Stock | $0 | +484K +37.44% | 1,775,293 2.13% of shares | low |
| Jan 22, 2026 | Jayagopal Ashwath Executive | Grant | Common Stock | $0 | +400K +317.95% | 525,807 0.63% of shares | low |
| Jan 1, 2026 | Ainsworth Sean Director | Grant | Common Stock | — | +43K +16.68% | 297,325 0.36% of shares | low |
| Jan 1, 2026 | Graves Adrienne L Director | Grant | Common Stock | — | +24K +29.74% | 103,147 0.12% of shares | low |
| Jan 1, 2026 | Manuso James S J Director | Grant | Common Stock | — | +31K +11.91% | 292,951 0.35% of shares | low |
| Jan 1, 2026 | Bennett Jean Director | Grant | Common Stock | — | +21K +9.89% | 234,652 0.28% of shares | low |